Message from the CEO

Every year, 15 million people worldwide suffer strokes. A third of them die within 30 days and another third are disabled for the rest of their lives. This causes patients a great deal of suffering and the cost to society is huge.

Mats Palerius - ZenicorAtrial fibrillation, the most common form of cardiac arrhythmia, is one of the main causes of strokes. 20 Swedes suffer strokes every day as a result of atrial fibrillation. Many people have undiagnosed atrial fibrillation. Research conducted over the past 10 years has established a link between atrial fibrillation and stroke.

In recent years, Zenicor Medical Systems has established itself as a leading player in atrial fibrillation diagnosis and stroke prevention.

Our solution, known as Zenicor-ECG, consists of a handheld device (a thumb ECG) that allows the patient to register short-term ECG episodes over an extended period of time. The episodes are automatically sent to a central database via the mobile network. A healthcare professional can then review the patient’s ECG online at any time and make a diagnosis.

Zenicor-ECG combines superior diagnostics with high cost-effectiveness and user-friendliness for both healthcare staff and patients. With Zenicor-ECG, it is possible to diagnose up to 4 times more people with atrial fibrillation than with other methods. This has been demonstrated in a number of research studies. Without correct diagnosis these people would run a high risk of suffering a stroke.

More than 350 clinics, primarily in Sweden and the Nordic region, currently use Zenicor-ECG. We have also started operating in Germany and the UK, and already have a number of customer installations in these countries.

 

Mats Palerius, CEO

Zenicor Medical Systems AB